Concepedia

Anton Hagenbeek

AH

Statistics

Publications

164

Citations

21.2K

H-Index

58

Active since

1973

Affiliations

Rotterdam University of Applied Sciences(Current)

Amsterdam UMC Location University of Amsterdam

University Medical Center Utrecht

Netherlands Organisation for Applied Scientific Research

Erasmus University Rotterdam

Anton Hagenbeek is an author at Rotterdam University of Applied Sciences specializing in medicine, oncology, and hematologic oncology.

Publications per year

1973–2021

164

Publications

164

Revised Response Criteria for Malignant Lymphoma

Bruce D. Cheson, Beate Pfistner, Malik E. Juweid et al. · Journal of Clinical Oncology · 2007 · 4.4K citations · Full text

Medicine, Oncology, Pathology +15

Autologous Bone Marrow Transplantation as Compared with Salvage Chemotherapy in Relapses of Chemotherapy-Sensitive Non-Hodgkin's Lymphoma

Thierry Philip, Cesare Guglielmi, Anton Hagenbeek et al. · New England Journal of Medicine · 1995 · 2.4K citations

Medicine, Hematology, Oncology +14

Rituximab maintenance for 2 years in patients with high tumour burden follicular lymphoma responding to rituximab plus chemotherapy (PRIMA): a phase 3, randomised controlled trial

Gilles Salles, John F. Seymour, Fritz Offner et al. · The Lancet · 2010 · 1.1K citations

Medicine, Oncology, Pharmacotherapy +6

Follicular lymphoma international prognostic index.

Pascal Roy, Philippe Colombat, Josephine M White et al. · PubMed · 2004 · 627 citations

Medicine, Hematology, Oncology +15

Rituximab maintenance improves clinical outcome of relapsed/resistant follicular non-Hodgkin lymphoma in patients both with and without rituximab during induction: results of a prospective randomized phase 3 intergroup trial

Marinus H. J. van Oers, Richard Klasa, Robert Marcus et al. · Blood · 2006 · 593 citations · Full text

Medicine, Oncology, Pharmacotherapy +13

1–5 of 164